Malaer, Joseph D CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma. [electronic resource] - American journal of cancer research 2017 - 1637-1641 p. digital Publication Type: Journal Article; Review ISSN: 2156-6976